After an illustrious career at Idaho National Laboratory spanning three decades, Curtis Smith is now sharing his expertise in risk analysis and management with future generations of engineers at MIT.
Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.
The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.
